Company: ZVRA
Filing Date: 2025-12-02
Form Type: 8-K
Source: 0001434647-25-000015
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-12-02
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

  (d)      Exhibits  

  Exhibit No.      Description                                                                                                                                                                                           
         99.1      Press Release dated December 2, 2025                                                                                                                                                                  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
         10.1      Tenth Amended and Restated Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.1 filed with the Company’s Quarterly Report on Form 10-Q filed on May 13, 2025 (Fil...  
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                                           

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                              Zevra Therapeutics, Inc.                                                               
  Date: December 2, 2025      By:                           /s/ Timothy J. Sangiovanni                               
                                                            Timothy J. Sangiovanni, CPA                              
                                                            Senior Vice President, Finance and Corporate Controller